Bluejay Diagnostics (BJDX) Accumulated Expenses (2020 - 2025)

Bluejay Diagnostics' Accumulated Expenses history runs 6 years deep, the most recent figure standing at $804942.0 for Q4 2025.

• In Q4 2025, Accumulated Expenses rose 45.83% year-over-year to $804942.0; the TTM figure through Dec 2025 stood at $804942.0 (up 45.83% YoY), while the FY2025 annual figure was $804942.0, up 45.83% from the prior year.
• Accumulated Expenses came in at $804942.0 for Q4 2025 at Bluejay Diagnostics, up from $74400.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.4 million in Q2 2023 to a low of $74400.0 in Q3 2025.
• A 5-year average of $646019.1 and a median of $592622.0 in 2022 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 190.79% in 2022 and sank 83.68% in 2025, its largest moves.
• Bluejay Diagnostics' Accumulated Expenses stood at $341384.0 in 2021, then soared by 144.81% to $835730.0 in 2022, then surged by 33.64% to $1.1 million in 2023, then plunged by 50.58% to $551986.0 in 2024, then jumped by 45.83% to $804942.0 in 2025.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $804942.0, $74400.0, and $164631.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison